Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.4K Sell
39
-561
-94% -$19.8K ﹤0.01% 720
2024
Q2
$21K Sell
600
-1,400
-70% -$44.4K 0.01% 482
2024
Q1
$60.4K Hold
2,000
0.02% 318
2023
Q4
$60.2K Hold
2,000
0.02% 321
2023
Q3
$51.4K Hold
2,000
0.02% 327
2023
Q2
$61.4K Buy
+2,000
New +$60K 0.03% 309
2022
Q4
Sell
-727
Closed -$18K 815
2022
Q3
$18K Buy
727
+6
+0.8% +$184 0.01% 490
2022
Q2
$24K Sell
721
-996
-58% -$36.6K 0.01% 433
2022
Q1
$62K Buy
1,717
+1,004
+141% +$37.1K 0.03% 315
2021
Q4
$27K Buy
713
+5
+0.7% +$164 0.01% 476
2021
Q3
$19K Buy
708
+4
+0.6% +$115 0.01% 519
2021
Q2
$21K Buy
704
+4
+0.6% +$128 0.01% 509
2021
Q1
$22K Buy
700
+5
+0.7% +$138 0.01% 485
2020
Q4
$17K Buy
695
+6
+0.9% +$126 0.01% 491
2020
Q3
$13K Buy
689
+7
+1% +$128 0.01% 492
2020
Q2
$12K Buy
682
+46
+7% +$731 0.01% 480
2020
Q1
$11K Sell
636
-34
-5% -$688 0.01% 447
2019
Q4
$14K Buy
+670
New +$12.7K 0.01% 441

Other funds holding HPQ

Carmichael Hill & Associates's HPQ Position: Q3 2024 in Review

Carmichael Hill & Associates reduced its HP (HPQ) stake by 94% in Q3 2024, selling an estimated $19.8K and leaving 39 shares worth $1.4K. The position accounts for ﹤0.01% of the portfolio, ranked #720.

Carmichael Hill & Associates first reported a position in HPQ in Q4 2019 and has held it in 18 quarters since. The position peaked at $62K in Q1 2022. 1,162 funds tracked by Wall St. Rank hold HPQ as of Q3 2024.

  • Carmichael Hill & Associates held 39 shares of HP worth $1.4K as of Q3 2024.
  • Carmichael Hill & Associates sold 561 HP shares in Q3 2024, an estimated $19.8K.
  • HP made up ﹤0.01% of Carmichael Hill & Associates's portfolio in Q3 2024, its #720 holding.
  • Carmichael Hill & Associates first reported a position in HP in Q4 2019 and has held it in 18 quarters since.
  • Carmichael Hill & Associates's HP position peaked at $62K in Q1 2022.
  • 1,162 funds tracked by Wall St. Rank held HP as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.